Related Experiment Video
Updated: Feb 3, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Targeting SOX2 in anticancer therapy
Laura Hüser1, Daniel Novak1, Viktor Umansky1
1a Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg and Department of Dermatology, Venereology and Allergology , University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg , Mannheim , Germany.
Introduction:
SOX2 is a transcription factor that is important in the development and maintenance of the stem cell state. Furthermore, SOX2 is associated with cancer progression because it promotes the migration, invasion, and proliferation of cancer cells. SOX2 is also expressed in cancer stem cells and appears to be involved in the resistance toward anticancer therapies. These features render SOX2 an attractive target for cancer therapy. Areas covered: In this review, we highlight the role of SOX2 in cancer and in the resistance toward anticancer therapies. We summarize recent studies dealing with SOX2 as a direct or indirect therapeutic target in cancer. Expert opinion: SOX2 is an attractive target in cancer therapy because of its role in cancer progression and therapy resistance. SOX2 is a transcription factor, hence direct targeting is difficult. Studies aimed at a functional depletion, for example by knock-down with siRNAs, are difficult to translate into clinical settings. Alternatively, the identification of SOX2 upstream or downstream regulators that are easier to target is of paramount importance.
Insights
SOX2, a key transcription factor, drives cancer progression and therapy resistance. Targeting SOX2 or its regulators offers a promising strategy for novel cancer treatments.
Area of Science:
- Oncology
- Molecular Biology
- Stem Cell Research
Background:
- SOX2 is a crucial transcription factor for stem cell maintenance.
- SOX2 promotes cancer cell migration, invasion, and proliferation.
- SOX2 expression in cancer stem cells correlates with resistance to therapies.
Purpose of the Study:
- To review the role of SOX2 in cancer progression.
- To summarize SOX2's involvement in anticancer therapy resistance.
- To discuss SOX2 as a therapeutic target in oncology.
Main Methods:
- Literature review of recent studies on SOX2 in cancer.
- Analysis of SOX2's function in cancer stem cells.
- Evaluation of therapeutic strategies targeting SOX2.
Main Results:
- SOX2 significantly contributes to cancer development and metastasis.
- SOX2 is implicated in the resistance of cancer cells to various treatments.
- SOX2 presents a viable, yet challenging, therapeutic target.
Conclusions:
- SOX2 is a critical factor in cancer progression and treatment resistance, making it an attractive therapeutic target.
- Directly targeting SOX2 is challenging due to its nature as a transcription factor.
- Identifying and targeting SOX2 upstream or downstream regulators is a key future direction for cancer therapy.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

